View 2021 Agenda Here


The focus of this 4-day virtual workshop is on understanding the complex causes underlying the emergence and spread of AMR, on identifying practical approaches to tackle antibiotic misuse in different settings, and discussing promising scientific advances related to AMR.




Course Directors

Makeda Semret, MSc, MD, FRCPC

Associate Professor of Medicine, Infectious Diseases and Medical Microbiology, McGill University
Lead, Antimicrobial Stewardship Program, McGill University Health Centre
Director, Training Program in Infectious Diseases and Medical Microbiology, McGill University


Erika Vlieghe MD
Head of the Department of General Internal Medicine, Infectious diseases and Tropical Medicine, University Hospital Antwerp
Professor of infectious diseases, University of Antwerp


Dao Nguyen, MSc, MD FRCP(C)
Associate Professor of Medicine, McGill University
AMR Center Lead, McGill Interdisciplinary Initiative in Infection and Immunity (MI4)



2021 Course Faculty

Alemseged Abdissa -Armauer Hansen Research Institute
Annelie Monnier – Radboud University Medical Center, the Netherlands.
Bastien Castagner – McGill University
Cedric Yansouni – McGill University
Christian Lavallee -Université de Montréal
Corinne Maurice – McGill University
Daniel de Vos- Queen Astrid Military Hospital, Brussels
Dao Nguyen – McGill University
Erika Vlieghe – University Hospital Antwerp
Heiman Wertheim – Radboud University, Netherlands
Ian Marr – Menzies School of Health Research – Australia
Iruka Okeke – Nigerian Academy of Sciences
Janne Vehreschild – German Centre for Infection Research (DZIF)
Jen Ronholm – McGill University
Jesse Shapiro – McGill University
Louis Valiquette – Université de Sherbrooke
Louis-Patrick Haraoui  – Université de Sherbrooke
Makeda Semret  – McGill University
Marcus Zervos – Henry Ford Health System
Pem Chuki – Khesar Gyalpo University of Medical Science
Raffaella Ravinetto – Institute of Tropical Medicine Antwerp
Sam Gruenheid – McGill University
Senjuthi Saha- Child Health Research Foundation
Stephane Bayen – McGill University
Tessa Wyllie -Menzies School of Health Research
Tinsae Alemayehu -American Medical Center
Yves Longtin – McGill University



Antimicrobial resistance (AMR) is now one the biggest threats facing modern medicine. Initially described mostly in association with hospital-associated infections in high-income countries, the highest rates of AMR are now reported from low and middle- income countries (LMIC) around the world. The causes underlying the global rise in AMR are complex, but
central to this crisis is overconsumption of antibiotics.


This 4-day virtual workshop will focus on understanding the complex causes underlying the emergence and spread of AMR, on approaches to tackle antibiotic misuse in different settings, and on discussing promising scientific advances related to AMR.


The workshop format is a mix of plenary talks and panel discussions, with opportunities to interact with course faculty and participants who work across the spectrum of the antimicrobial resistance space indifferent countries.


Clinicians, researchers, implementers, and health educators from both high-income and low and middle-income countries will share questions, successes, and lessons learned to advance the field of AMR.



At the end of this course, participants will be able to:
– Understand the basic mechanisms and trends in Antimicrobial resistance
– Describe essential diagnostic tools and challenges/opportunities for improved AMR surveillance in different settings
– Identify adaptive challenges and practical solutions to implementing stewardship programs in different settings
– Understand the emerging issues in antimicrobial use and resistance in agriculture and natural environments, and their potential link to human health
– Discuss promising advances in AMR-related biomedical research




This course appeals to a wide range of participants including:

  • Clinicians, pharmacists, technologists, researchers and students studying infectious diseases, tropical medicine, or global health
  • Policy makers and public health agency officials
  • Product developers and funders
  • Community advocacy groups working in global health